新型冠状病毒感染相关咳嗽诊治专家共识
中华医学会呼吸病学分会哮喘学组与国家呼吸医学中心组织专家制定本共识,涵盖流行病学与发病机制、临床表现、诊断与鉴别诊断、治疗和展望五部分,以指导临床医生规范诊治新型冠状病毒感染相关咳嗽。
要点
- 急性咳嗽发生率44%-72.5%,约三分之一为咳痰性咳嗽。
- 咳嗽平均持续时间约2周,部分患者可持续数月。
- 急性期诊断依赖流行病学史、临床特征、体检及抗原或核酸检测。
核心结论
- 共识旨在指导医生规范诊治SARS-CoV-2感染相关咳嗽,涵盖流行病学、机制、临床表现、诊断与治疗。
研究设计与样本
- 由中华医学会呼吸病学分会哮喘学组与国家呼吸医学中心组织相关专家制定的专家共识。
主要发现
- 急性咳嗽发生率为44%-72.5%,约三分之一为咳痰性咳嗽。
- 目前数据显示咳嗽平均持续时间约2周,但部分患者咳嗽可持续更久,甚至数月。
- SARS-CoV-2感染咳嗽与气道上皮损伤、免疫原性或神经源性炎症、气道黏液高分泌及咳嗽高敏感性(外周或中枢)相关。
关键数值与推荐
- 急性期诊断依据流行病学史、临床特征、体格检查及SARS-CoV-2抗原或核酸检测,并需与其他呼吸道感染后咳嗽鉴别。
- 急性与亚急性期咳嗽目前对症治疗,根据咳嗽类型使用镇咳药和祛痰药;严重咳嗽可使用中枢性或外周性镇咳药。
- 推荐联合第一代抗组胺药/减充血剂(A/D制剂)。
- 重症或可能发展为重症的患者使用Paxlovid等抗病毒治疗;除有细菌感染特征外不推荐抗菌治疗。
- 吸入糖皮质激素或激素联合长效β2受体激动剂或白三烯拮抗剂仅用于有喘息、哮喘或过敏史、嗜酸性炎症证据或镇咳治疗无效的患者。
临床怎么用
- COPD或哮喘等慢性呼吸疾病患者应维持常规治疗。
- 中医治疗在急性期或非急性期根据临床实践显示有效,更多证据正在收集中。
局限性
- 关于SARS-CoV-2相关咳嗽的流行病学、发病机制、咳嗽特征、治疗和预后数据有限,需更多研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cough is a common symptom in the acute phase of novel coronavirus SARS-CoV-2 infection, and some patients may develop persistent cough (subacute cough or even chronic cough), which affects the quality of life. Currently, the Omicron variant of SARS-CoV-2 infection is still widespread in China. In order to guide physicians on the diagnosis and treatment of SARS-CoV-2-associated cough, the Asthma Group of the Chinese Thoracic Society and the National Centre for Respiratory Medicine organized relevant experts to develop the Expert Consensus on the Diagnosis and Treatment of SARS-CoV-2-associated Cough. This consensus includes five parts: epidemiology and pathogenesis, clinical manifestations, diagnosis and differential diagnosis, treatment and outlook.The incidence of acute cough is 44%-72.5%, and about one third is productive cough. Current data shows that the average duration of cough is proximately 2 weeks, but in some patients, cough could last longer, even up to several months. SARS-CoV-2 infection cough is associated with airway epithelial damage, immunogenic or neurogenic inflammation, airway mucus hypersecretion, and cough hypersensitivity (peripheral or central).The diagnosis of SARS-CoV-2-associated cough in acute phase relies on epidemiological history, clinical characteristics, physical examination, and SARS-CoV-2 antigen or nucleic acid tests. It is also important to distinguish it from cough following other respiratory infections. The patients in acute and subacute phases of cough are currently treated symptomatically, by using cough suppressants and expectorants according to the types of the cough. For patients with severe cough, central or peripheral cough suppressants can be used. Combined first-generation antihistamines/decongestants (A/D preparations) are recommended. Anti-viral treatment such as Paxlovid is used in severe patients or patients who are likely to develop severe conditions. Anti-bacterial treatment is not recommended except for patients with bacterial infectious traits. Inhaled corticosteroids or corticosteroids plus long acting beta agonists or leukotriene antagonists are only used for patients with wheezing, or those who have asthma or allergy history, or who have evidence of eosinophilic inflammation or who are refractory to antitussive treatment. Patients who have chronic respiratory diseases such as COPD or asthma should maintain the regular treatments. With regard to TCM treatment, effectiveness is indicated both in the acute phase or non-acute phase based on clinical practice, and collection of more evidence on this aspect is also under way.There is limited data on SARS-CoV-2-associated cough in regard of epidemiology, pathogenesis, features of cough, treatment, and prognosis. More studies are warranted to improve our understanding and management of SARS-CoV-2-associated cough in the future. 咳嗽是新型冠状病毒SARS-CoV-2感染急性期的常见症状,部分患者可发展为持续性咳嗽(亚急性咳嗽甚至慢性咳嗽),严重影响生活质量。目前,新型冠状病毒的奥密克戎变异株感染在中国仍然十分普遍,中华医学会呼吸病学分会哮喘学组与国家呼吸医学中心组织相关专家制定了本共识,共识的主要内容包括以下5个部分:流行病学与发病机制、临床表现、诊断与鉴别诊断、治疗和展望,以期及时指导广大临床医生规范诊治新型冠状病毒感染相关咳嗽。.
引用
- [Expert consensus on the diagnosis and treatment of SARS-CoV-2-associated cough]. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 36642495. doi:10.3760/cma.j.cn112147-20230109-00010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。